VASCONCELLES MICHAEL 4
4 · Day One Biopharmaceuticals, Inc. · Filed Jun 18, 2025
Insider Transaction Report
Form 4
VASCONCELLES MICHAEL
Head of Research and Dev.
Transactions
- Award
Stock Option (right to buy Common Stock)
2025-06-16+346,000→ 346,000 totalExercise: $6.64Exp: 2035-06-15→ Common Stock (346,000 underlying) - Award
Restricted Stock Unit (RSU)
2025-06-16+226,000→ 226,000 totalExercise: $0.00→ Common Stock (226,000 underlying)
Footnotes (4)
- [F1]The option vests as to 1/4th of the total grant on June 16, 2026, and 1/48th of the total grant will vest on each monthly anniversary thereafter, subject to the Reporting Person's provision of service to the Issuer on each option vesting date.
- [F2]Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock upon settlement for no consideration.
- [F3]The RSUs vest as to 25% of the total award on August 15, 2026, and 1/12th of the remaining RSUs vest in quarterly installments thereafter on November 15, February 15, May 15 and August 15, subject to the Reporting Person's provision of service to the Issuer on each RSU vesting date.
- [F4]RSUs do not expire; they either vest or are canceled prior to the RSU vesting date..